VANGUARD GROUP INC 13D and 13G filings for Health Catalyst, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 3:55 pm Unchanged |
2024-09-30 | 13G | Health Catalyst, Inc. HCAT |
VANGUARD GROUP INC | 4,580,563 7.570% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:52 am Sale |
2024-09-30 | 13G | Health Catalyst, Inc. HCAT |
VANGUARD GROUP INC | 4,580,563 7.570% |
-927,409 (-16.84%) |
Filing |
| 2024-02-13 5:06 pm Sale |
2023-12-29 | 13G | Health Catalyst, Inc. HCAT |
VANGUARD GROUP INC | 5,507,972 9.570% |
-561,556 (-9.25%) |
Filing |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | Health Catalyst, Inc. HCAT |
VANGUARD GROUP INC | 6,069,528 11.090% |
577,017 (+10.51%) |
Filing |
| 2022-08-10 09:34 am Purchase |
2022-07-29 | 13G | Health Catalyst, Inc. HCAT |
VANGUARD GROUP INC | 5,492,511 10.140% |
1,209,772 (+28.25%) |
Filing |
| 2022-02-10 08:16 am Purchase |
2021-12-31 | 13G | Health Catalyst, Inc. HCAT |
VANGUARD GROUP INC | 4,282,739 8.230% |
1,398,107 (+48.47%) |
Filing |
| 2021-02-10 10:57 am Purchase |
2020-12-31 | 13G | Health Catalyst, Inc. HCAT |
VANGUARD GROUP INC | 2,884,632 6.790% |
2,884,632 (New Position) |
Filing |